Citadel Advisors’s Monogram Orthopaedics MGRM Stock Holding History

Citadel Advisors’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,051	Closed	-$241K	–	13532
2025 Q3	$241K	Buy	+41,051	New	+$219K	﹤0.01%	10846

Citadel Advisors's MGRM Position: Q4 2025 in Review

Citadel Advisors sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 41,051 shares — an estimated $241K sold.

Citadel Advisors first reported a position in MGRM in Q3 2025 and held it in 1 quarter. The position peaked at $241K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

Citadel Advisors reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
Citadel Advisors sold 41,051 Monogram Orthopaedics shares in Q4 2025, an estimated $241K.
Citadel Advisors first reported a position in Monogram Orthopaedics in Q3 2025 and held it in 1 quarter.
Citadel Advisors's Monogram Orthopaedics position peaked at $241K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.